SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Reiner Zeljko) "

Sökning: WFRF:(Reiner Zeljko)

  • Resultat 21-22 av 22
  • Föregående 12[3]
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
21.
  • Zannad, Faiez, et al. (författare)
  • Prevention of cardiovascular disease guided by total risk estimations - challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy.
  • 2012
  • Ingår i: European Journal of Preventive Cardiology. - 2047-4873 .- 2047-4881. ; 19:6, s. 1454-1464
  • Forskningsöversikt (refereegranskat)abstract
    • This paper presents a summary of the potential practical and economic barriers to implementation of primary prevention of cardiovascular disease guided by total cardiovascular risk estimations in the general population. It also reviews various possible solutions to overcome these barriers. The report is based on discussion among experts in the area at a special CardioVascular Clinical Trialists workshop organized by the European Society of Cardiology Working Group on Cardiovascular Pharmacology and Drug Therapy that took place in September 2009. It includes a review of the evidence in favour of the 'treat-to-target' paradigm, as well as potential difficulties with this approach, including the multiple pathological processes present in high-risk patients that may not be adequately addressed by this strategy. The risk-guided therapy approach requires careful definitions of cardiovascular risk and consideration of clinical endpoints as well as the differences between trial and 'real-world' populations. Cost-effectiveness presents another issue in scenarios of finite healthcare resources, as does the difficulty of documenting guideline uptake and effectiveness in the primary care setting, where early modification of risk factors may be more beneficial than later attempts to manage established disease. The key to guideline implementation is to improve the quality of risk assessment and demonstrate the association between risk factors, intervention, and reduced event rates. In the future, this may be made possible by means of automated data entry and various other measures. In conclusion, opportunities exist to increase guideline implementation in the primary care setting, with potential benefits for both the general population and healthcare resources.
  •  
22.
  • Zannad, Faiez, et al. (författare)
  • Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques
  • 2012
  • Ingår i: Fundamental and Clinical Pharmacology. - 0767-3981 .- 1472-8206. ; 26:2, s. 163-174
  • Forskningsöversikt (refereegranskat)abstract
    • The aim of this paper is to review and discuss current methods of risk stratification for cardiovascular disease (CVD) prevention, emerging biomarkers, and imaging techniques, and their relative merits and limitations. This report is based on discussions that took place among experts in the area during a special CardioVascular Clinical Trialists workshop organized by the European Society of Cardiology Working Group on Cardiovascular Pharmacology and Drug Therapy in September 2009. Classical risk factors such as blood pressure and low-density lipoprotein cholesterol levels remain the cornerstone of risk estimation in primary prevention but their use as a guide to management is limited by several factors: (i) thresholds for drug treatment vary with the available evidence for cost-effectiveness and benefit-to-risk ratios; (ii) assessment may be imprecise; (iii) residual risk may remain, even with effective control of dyslipidemia and hypertension. Novel measures include C-reactive protein, lipoprotein-associated phospholipase A 2, genetic markers, and markers of subclinical organ damage, for which there are varying levels of evidence. High-resolution ultrasound and magnetic resonance imaging to assess carotid atherosclerotic lesions have potential but require further validation, standardization, and proof of clinical usefulness in the general population. In conclusion, classical risk scoring systems are available and inexpensive but have a number of limitations. Novel risk markers and imaging techniques may have a place in drug development and clinical trial design. However, their additional value above and beyond classical risk factors has yet to be determined for risk-guided therapy in CVD prevention. © 2012 The Authors Fundamental and Clinical Pharmacology © 2012 Société Française de Pharmacologie et de Thérapeutique.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 21-22 av 22
  • Föregående 12[3]
Typ av publikation
tidskriftsartikel (19)
forskningsöversikt (3)
Typ av innehåll
refereegranskat (21)
övrigt vetenskapligt (1)
Författare/redaktör
Reiner, Željko (22)
Dean, Veronica (12)
Tendera, Michal (10)
Kolh, Philippe (10)
De Backer, Guy (10)
Vahanian, Alec (10)
visa fler...
Sechtem, Udo (10)
Fagard, Robert (9)
Knuuti, Juhani (8)
Windecker, Stephan (8)
Zamorano, Jose Luis (8)
McDonagh, Theresa (8)
Ceconi, Claudio (8)
Deaton, Christi (8)
Ryden, Lars (7)
Widimsky, Petr (7)
Torbicki, Adam (7)
Hasdai, David (7)
Baumgartner, Helmut (7)
Cifkova, Renata (7)
Kirchhof, Paulus (7)
Atar, Dan (6)
Ponikowski, Piotr (6)
Filippatos, Gerasimo ... (6)
Reiner, Z (6)
De Backer, G (6)
Auricchio, Angelo (6)
Cifkova, R (6)
Graham, Ian (6)
Rydén, L. (5)
Fras, Zlatko (5)
Perk, Joep (5)
Zannad, Faiez (5)
Lip, Gregory Y H (5)
Bax, Jeroen J (5)
Mancia, Giuseppe (5)
Lancellotti, Patrizi ... (4)
Anker, Stefan D (4)
Piepoli, Massimo F. (4)
De Caterina, Raffael ... (4)
Wood, D (4)
Dickstein, Kenneth (4)
Dallongeville, Jean (4)
Catapano, Alberico L ... (4)
Banach, Maciej (4)
Bruckert, Eric (4)
Viigimaa, Margus (4)
Wijns, William (4)
Nihoyannopoulos, Pet ... (4)
Gorenek, Bulent (4)
visa färre...
Lärosäte
Göteborgs universitet (7)
Uppsala universitet (6)
Karolinska Institutet (6)
Linnéuniversitetet (5)
Linköpings universitet (4)
Lunds universitet (2)
visa fler...
Umeå universitet (1)
visa färre...
Språk
Engelska (22)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (10)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy